Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally

Focused on precision oncology and rare genetic diseases, this biotech reported a significant insider sale amid strong ...

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight ...

7 Most Promising Gene Editing Stocks According to Analysts

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...
IEEE

A Bayesian Implementation of Quality-by-Design for the Development of Cationic Nano-Lipid for siRNA Transfection

Abstract: Unlike Quality by Testing approach, where products were tested only after drug manufacturing, Quality by Design (QbD) is a proactive control quality paradigm, which handles risks from the ...
Frontiers

A novel PolyAr87-based cell transfection protocol for nanobody expression optimized via a targeted Design of Transfection approach

Model validation demonstrated strong predictive power and reproducibility. These findings confirm both the effectiveness of PolyAr87 as a cost-efficient transfection reagent and the utility of ...

Non-Viral Gene Delivery Technologies Market Size to Hit USD 9.57 Billion by 2033, Growing at a CAGR of 12.55% - SNS Insider

Rising demand for safer gene delivery methods, rapid advancements in gene therapy research, and expanding applications in oncology and rare diseases are accelerating the non-viral gene delivery ...